![](/img/cover-not-exists.png)
WS13.3 Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: the international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF)
Konstan, M.W., DiMango, E., Kerem, E., Melotti, P., Rowe, S., Sermet-Gaudelus, I., Wilschanski, M., McIntosh, J., Sun, Y., De Boeck, K.Volume:
16
Language:
english
Journal:
Journal of Cystic Fibrosis
DOI:
10.1016/s1569-1993(17)30233-3
Date:
June, 2017
File:
PDF, 81 KB
english, 2017